Action Glycogenesys - GLGS

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

GlycoGenesys, Inc. Announces Chapter 11 Filing, Reduction in Work Force and Senior Management Changes

Company Significantly Reduces Expenses To Pursue Strategic Alternatives While Maintaining Multiple Myeloma Clinical Trial BOSTON, Feb. 3...

GlycoGenesys, Inc. Requests Hearing to Appeal Nasdaq Staff Determination

GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company, today announced that it requested a hearing before a Nasdaq Listing Qualifications...

GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial Results and Stock Listing Status; Quarterly Conference Call Schedule

GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company focused on drug development, today commented on results from its Form 10-Q for the...

GlycoGenesys Initiates Additional Prestigious Medical Site for GCS-100 Phase I/II Multiple Myeloma Clinical Trial; Patient Scree

GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company, today announced it has initiated Roswell Park Cancer Institute, (RPCI) Buffalo, New...

GlycoGenesys to Present at the Bio-Europe 2005 Partnering Conference

GlycoGenesys, Inc. (Nasdaq: GLGS), a biotechnology company, announced today that Frederick E. Pierce, II, VP of Business Development will make a...

GlycoGenesys to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

GlycoGenesys, Inc.. (Nasdaq: GLGS), a biotechnology company, announced today that John W. Burns, Sr. VP. And CFO will present at the Rodman...

GlycoGenesys, Inc. Announces $20.0 Million Common Stock Purchase Agreement with Fusion Capital

GlycoGenesys, Inc. (Nasdaq: GLGS), a biotechnology company, today announced it has entered into a common stock purchase agreement with Fusion...

ChineseWorldNet.com Inc. to Host Global Chinese Financial Forum in Toronto

VANCOUVER, British Columbia, Sept 27 /PRNewswire/ -- ChineseWorldNet.com Inc. is proud to present the third annual Global Chinese Financial...

New Preclinical Discovery Shows GlycoGenesys' Cancer Drug Candidate GCS-100 Inhibits AKT1 (Promoter of Cancer Cell Survival and

Data Presented At The XI International Work Shop on Chronic Lymphocytic Leukemia ? GlycoGenesys, Inc., (NASDAQ: GLGS), a biotechnology...

New Mechanistic Frame Work For GlycoGenesys' Cancer Drug Candidate GCS-100 Published in The Journal Cancer Research

? GCS-100 Targets Galectin-3 in Multiple Myeloma Cells In Vitro, Leading to Increased Anti-Tumor Activity When Combined With Dexamethasone ?...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

GLGS - Frequently Asked Questions (FAQ)

What is the current Glycogenesys share price?

The current share price of Glycogenesys is US$ 0,00

What is the 1 year trading range for Glycogenesys share price?

Glycogenesys has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CAPSCapstone Holding Corp	US$ 3,50 (1 300,00%)	36,33k
ABLVAble View Global Inc	US$ 1,73 (137,18%)	5,13M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	476,73M
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	618,03M
DWTXDogwood Therapeutics Inc	US$ 6,63 (49,66%)	25,77M
ALBTAvalon GloboCare Corporation	US$ 6,96 (-36,15%)	570,43k
SCNXScienture Holdings Inc	US$ 1,55 (-35,68%)	1,54M
ACXPAcurx Pharmaceuticals Inc	US$ 0,4572 (-29,88%)	1,13M
RETOReTo Eco Solutions Inc	US$ 5,42 (-27,73%)	108k
OCTOEightco Holdings Inc	US$ 1,08 (-27,03%)	332,1k
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	622,67M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	482,05M
NVDANVIDIA Corporation	US$ 112,69 (1,92%)	341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10,675 (-0,70%)	143,04M
ICONIcon Energy Corporation	US$ 0,169898 (17,17%)	142,23M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Glycogenesys Inc. (MM) (GLGS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

GLGS Dernières nouvelles

GlycoGenesys, Inc. Announces Chapter 11 Filing, Reduction in Work Force and Senior Management Changes

GlycoGenesys, Inc. Requests Hearing to Appeal Nasdaq Staff Determination

GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial Results and Stock Listing Status; Quarterly Conference Call Schedule

GlycoGenesys Initiates Additional Prestigious Medical Site for GCS-100 Phase I/II Multiple Myeloma Clinical Trial; Patient Scree

GlycoGenesys to Present at the Bio-Europe 2005 Partnering Conference

GlycoGenesys to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

GlycoGenesys, Inc. Announces $20.0 Million Common Stock Purchase Agreement with Fusion Capital

ChineseWorldNet.com Inc. to Host Global Chinese Financial Forum in Toronto

New Preclinical Discovery Shows GlycoGenesys' Cancer Drug Candidate GCS-100 Inhibits AKT1 (Promoter of Cancer Cell Survival and

New Mechanistic Frame Work For GlycoGenesys' Cancer Drug Candidate GCS-100 Published in The Journal Cancer Research

GLGS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Glycogenesys Inc. (MM) (GLGS) Cours

Glycogenesys Inc. (MM) (GLGS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

GLGS Dernières nouvelles

GlycoGenesys, Inc. Announces Chapter 11 Filing, Reduction in Work Force and Senior Management Changes

GlycoGenesys, Inc. Requests Hearing to Appeal Nasdaq Staff Determination

GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial Results and Stock Listing Status; Quarterly Conference Call Schedule

GlycoGenesys Initiates Additional Prestigious Medical Site for GCS-100 Phase I/II Multiple Myeloma Clinical Trial; Patient Scree

GlycoGenesys to Present at the Bio-Europe 2005 Partnering Conference

GlycoGenesys to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

GlycoGenesys, Inc. Announces $20.0 Million Common Stock Purchase Agreement with Fusion Capital

ChineseWorldNet.com Inc. to Host Global Chinese Financial Forum in Toronto

New Preclinical Discovery Shows GlycoGenesys' Cancer Drug Candidate GCS-100 Inhibits AKT1 (Promoter of Cancer Cell Survival and

New Mechanistic Frame Work For GlycoGenesys' Cancer Drug Candidate GCS-100 Published in The Journal Cancer Research

GLGS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS